Daiwa Securities Group’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12
| Closed | – | – | 1330 |
|
|
2023
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 1292 |
|
|
2023
Q2 | $0 | Sell |
12
-615
| -98% | -$34.8K | ﹤0.01% | 1324 |
|
|
2023
Q1 | $45K | Buy |
627
+121
| +24% | +$11.7K | ﹤0.01% | 1052 |
|
|
2022
Q4 | $41K | Buy |
506
+56
| +12% | +$5.84K | ﹤0.01% | 1056 |
|
|
2022
Q3 | $43K | Sell |
450
-119
| -21% | -$13.4K | ﹤0.01% | 1072 |
|
|
2022
Q2 | $111K | Buy |
569
+557
| +4,642% | +$90.9K | ﹤0.01% | 1012 |
|
|
2022
Q1 | $3K | Hold |
12
| – | – | ﹤0.01% | 1209 |
|
|
2021
Q4 | $5K | Hold |
12
| – | – | ﹤0.01% | 1191 |
|
|
2021
Q3 | $5K | Buy |
12
+6
| +100% | +$2.15K | ﹤0.01% | 1174 |
|
|
2021
Q2 | $2K | Hold |
6
| – | – | ﹤0.01% | 1135 |
|
|
2021
Q1 | $2K | Hold |
6
| – | – | ﹤0.01% | 1136 |
|
|
2020
Q4 | $3K | Sell |
6
-10
| -63% | -$4.62K | ﹤0.01% | 1079 |
|
|
2020
Q3 | $5K | Buy |
16
+4
| +33% | +$1.36K | ﹤0.01% | 1088 |
|
|
2020
Q2 | $3K | Hold |
12
| – | – | ﹤0.01% | 1136 |
|
|
2020
Q1 | $3K | Hold |
12
| – | – | ﹤0.01% | 1133 |
|
|
2019
Q4 | $5K | Sell |
12
-2
| -14% | -$690 | ﹤0.01% | 1104 |
|
|
2019
Q3 | $5K | Buy |
14
+2
| +17% | +$746 | ﹤0.01% | 1073 |
|
|
2019
Q2 | $6K | Hold |
12
| – | – | ﹤0.01% | 1081 |
|
|
2019
Q1 | $12K | Buy |
12
+4
| +50% | +$3.72K | ﹤0.01% | 1022 |
|
|
2018
Q4 | $7K | Hold |
8
| – | – | ﹤0.01% | 1021 |
|
|
2018
Q3 | $9K | Hold |
8
| – | – | ﹤0.01% | 1045 |
|
|
2018
Q2 | $8K | Hold |
8
| – | – | ﹤0.01% | 1064 |
|
|
2018
Q1 | $8K | Buy |
+8
| New | +$7.29K | ﹤0.01% | 1044 |
|
Other funds holding ATRA
EC
RG
